Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GENOCEA BIOSCIENCES, INC. | 75,000 | reported | 07 Feb 2019 | tx 2+85,000 |
| Aldeyra Therapeutics, Inc. | 7,500 | reported | 18 Mar 2026 | tx 2+7,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Mar 2026 | PURCHASE | Aldeyra Therapeutics, Inc. | 5,000 | 1.42 USD | |
| 13 Aug 2025 | PURCHASE | Aldeyra Therapeutics, Inc. | 2,500 | 5.30 USD | first after silence |
| 07 Feb 2019 | GRANT_AWARD | GENOCEA BIOSCIENCES, INC. | 75,000 | 0.00 USD | deriv |
| 13 Sept 2018 | PURCHASE | GENOCEA BIOSCIENCES, INC. | 10,000 | 0.54 USD |
1 purchase reported after at least 12 months of silence — most recent on 13 Aug 2025.